Miriam Komaromy, MD, medical director of BMC's Grayken Center for Addiction, cautions that the new rules don't go far enough in addressing opioid overdose deaths.
A discussion with the medical director of the National Harm Reduction Coalition sheds light on structural failures that impact people with substance use.
Word choice can perpetuate or undermine the dangerous stigma surrounding addiction. Advocates are trying to move the needle in the right direction.
Understanding the reasons for self-treatment and targeting community settings may help providers reach people who avoid necessary care, a new study suggests.
An HIV and addiction expert shares his insights into the evolving presence of methamphetamine in the opioid crisis and its implications for curbing substance use disorder.